Viveve Gets FDA Clearance for its Viveve System

Viveve has received FDA 510(k) marketing clearance for its Viveve System.

The device is designed for use in general surgical procedures for electrocoagulation and hemostasis.

Viveve has also applied for an IDE exemption to test the device in a study as a non-surgical treatment for post-partum laxity of the vaginal introitus. — Cynthia Jessup